24 august 2012
Prostate cancer survival rates have improved since the introduction of prostate specific antigen (PSA) testing, research has revealed.
A study published in the Journal of Urology found that the routine use of PSA testing has resulted in earlier and more sensitive detection of the disease.
Furthermore, survival has increased for patients who have prostate cancer that has just been diagnosed and has spread to other parts of the body.
Lead investigator Ian M Thompson Jr, added: "Our analysis indicates an overall improvement in risk adjusted survival rates for non-African American and African American men. Of note is the resolution of disparity in survival between the races found in earlier studies."
There was found to be a 30 per cent decreased risk of death in the most recent trial, which enrolled patients from 1995 to 2009, compared to the previous one, which took place between 1989 and 1994.
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.